HK1203852A1 - Benzhydrol pyrazole derivatives having kinase inhibitory activity and uses thereof - Google Patents
Benzhydrol pyrazole derivatives having kinase inhibitory activity and uses thereofInfo
- Publication number
- HK1203852A1 HK1203852A1 HK15104751.4A HK15104751A HK1203852A1 HK 1203852 A1 HK1203852 A1 HK 1203852A1 HK 15104751 A HK15104751 A HK 15104751A HK 1203852 A1 HK1203852 A1 HK 1203852A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- benzhydrol
- inhibitory activity
- pyrazole derivatives
- kinase inhibitory
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261584569P | 2012-01-09 | 2012-01-09 | |
PCT/US2013/020834 WO2013106432A1 (en) | 2012-01-09 | 2013-01-09 | Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1203852A1 true HK1203852A1 (en) | 2015-11-06 |
Family
ID=48781860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15104751.4A HK1203852A1 (en) | 2012-01-09 | 2015-05-19 | Benzhydrol pyrazole derivatives having kinase inhibitory activity and uses thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US9394256B2 (ja) |
EP (1) | EP2802324A4 (ja) |
JP (4) | JP6131272B2 (ja) |
CN (1) | CN104302289A (ja) |
AU (3) | AU2013208104B2 (ja) |
CA (1) | CA2862832A1 (ja) |
HK (1) | HK1203852A1 (ja) |
WO (1) | WO2013106432A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9394256B2 (en) * | 2012-01-09 | 2016-07-19 | X-Chem, Inc. | Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof |
US11104668B2 (en) | 2013-12-13 | 2021-08-31 | Hoffmann-La Roche Inc. | Inhibitors of bruton's tyrosine kinase |
EP3288384A4 (en) * | 2015-05-01 | 2019-01-23 | Georgia State University Research Foundation | BENZHYDROL DERIVATIVES FOR ADMINISTERING CONDITIONS RELATED TO HYPOXIC INDUCIBLE FACTORS |
WO2017157873A1 (en) | 2016-03-17 | 2017-09-21 | F. Hoffmann-La Roche Ag | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
CN111662270A (zh) * | 2019-03-05 | 2020-09-15 | 中国医学科学院药物研究所 | 碘同位素标记苄苯醚衍生物、及其制法和药物组合物与用途 |
MX2021015996A (es) | 2019-07-11 | 2022-06-08 | Escape Bio Inc | Indazoles y azaindazoles como inhibidores de cinasa de repetición rica en leucina 2 (lrrk2). |
CN112920245B (zh) * | 2019-12-05 | 2023-11-07 | 成都先导药物开发股份有限公司 | 一种合成On-DNA二氢吡唑化合物的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19629828A1 (de) * | 1996-07-24 | 1998-01-29 | Bayer Ag | Carbanilide |
EP1651612B9 (en) * | 2003-07-22 | 2012-09-05 | Astex Therapeutics Limited | 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
US20090221599A1 (en) * | 2006-03-20 | 2009-09-03 | Edward Boyd | Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents |
JP2009530342A (ja) * | 2006-03-20 | 2009-08-27 | エフ.ホフマン−ラ ロシュ アーゲー | Btkおよびsyk蛋白キナーゼを阻害する方法 |
JP5587193B2 (ja) * | 2007-10-23 | 2014-09-10 | エフ.ホフマン−ラ ロシュ アーゲー | 新規なキナーゼ阻害剤 |
FR2947546B1 (fr) * | 2009-07-03 | 2011-07-01 | Sanofi Aventis | Derives de pyrazoles, leur preparation et leur application en therapeutique |
US9394256B2 (en) * | 2012-01-09 | 2016-07-19 | X-Chem, Inc. | Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof |
-
2013
- 2013-01-09 US US14/370,854 patent/US9394256B2/en active Active
- 2013-01-09 CA CA2862832A patent/CA2862832A1/en not_active Abandoned
- 2013-01-09 EP EP13735755.4A patent/EP2802324A4/en not_active Withdrawn
- 2013-01-09 JP JP2014551417A patent/JP6131272B2/ja active Active
- 2013-01-09 AU AU2013208104A patent/AU2013208104B2/en not_active Ceased
- 2013-01-09 WO PCT/US2013/020834 patent/WO2013106432A1/en active Application Filing
- 2013-01-09 CN CN201380013198.0A patent/CN104302289A/zh active Pending
-
2015
- 2015-05-19 HK HK15104751.4A patent/HK1203852A1/xx unknown
-
2017
- 2017-04-17 JP JP2017081001A patent/JP2017149755A/ja active Pending
-
2018
- 2018-02-22 AU AU2018201295A patent/AU2018201295B2/en not_active Ceased
- 2018-10-11 JP JP2018192198A patent/JP2019048813A/ja active Pending
-
2020
- 2020-02-27 AU AU2020201447A patent/AU2020201447A1/en not_active Abandoned
- 2020-08-05 JP JP2020132835A patent/JP2020189852A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2013208104A8 (en) | 2014-09-11 |
EP2802324A4 (en) | 2015-07-15 |
CN104302289A (zh) | 2015-01-21 |
CA2862832A1 (en) | 2013-07-18 |
WO2013106432A1 (en) | 2013-07-18 |
JP6131272B2 (ja) | 2017-05-17 |
AU2018201295B2 (en) | 2019-11-28 |
EP2802324A1 (en) | 2014-11-19 |
JP2019048813A (ja) | 2019-03-28 |
AU2018201295A1 (en) | 2018-03-15 |
AU2020201447A1 (en) | 2020-03-19 |
JP2017149755A (ja) | 2017-08-31 |
AU2013208104B2 (en) | 2017-11-23 |
US9394256B2 (en) | 2016-07-19 |
JP2020189852A (ja) | 2020-11-26 |
AU2013208104A1 (en) | 2014-07-24 |
JP2015506362A (ja) | 2015-03-02 |
US20150005345A1 (en) | 2015-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1215577A1 (zh) | 蛋白激酶抑制劑 | |
HK1216147A1 (zh) | 取代的苯甲酰基 -氟- -亞氨基- -甲基- -二氫嘧啶- -酮衍生物 | |
HK1203852A1 (en) | Benzhydrol pyrazole derivatives having kinase inhibitory activity and uses thereof | |
EP2828258A4 (en) | NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE | |
PT2955185T (pt) | Inibidores da atividade de cinase de pirazole substituído policíclico e sua utilização | |
EP2833889A4 (en) | PROTEIN KINASE C HEMMER AND USES THEREOF | |
HK1208678A1 (en) | 3,5-diaminopyrazole kinase inhibitors 35- | |
HK1209277A1 (en) | 1,2,4-triazine-6-carboxamide kinase inhibitors 124--6- | |
HK1209726A1 (en) | Protein kinase inhibitors | |
HK1205506A1 (en) | Protein kinase inhibitors | |
EP2834246A4 (en) | COMBINED PRODUCTS COMPRISING TYROSINE KINASE INHIBITORS AND THEIR USE | |
HK1208460A1 (en) | Protein kinase inhibitors | |
EP2879679A4 (en) | ANTIBACTERIAL PROTEIN KINASE INHIBITORS | |
HK1198833A1 (en) | N-acylpeptide derivatives and their uses n- | |
SG11201504142WA (en) | Inhibitory oligonucleotide and use thereof | |
HK1210036A1 (en) | Aminoisoquinoline derivatives as protein kinase inhibitors | |
EP2876107A4 (en) | ISOCHINOLINE-5-CARBOXAMIDE DERIVATIVITY WITH PROTEIN CHINESE-DAMAGING EFFECT | |
EP2754659A4 (en) | 4-SUBSTITUTED- (3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO) -PYRIMIDINES DERIVATIVES HAVING PROTEIN KINASE INHIBITION ACTIVITY AND USE THEREOF | |
SI2882715T1 (sl) | Derivati pirazola in njihova uporaba kot antagonisti LPAR5 | |
HK1203848A1 (en) | Tryptoline derivatives having kinase inhibitory activity and uses thereof tryptoline | |
GB201219296D0 (en) | Pyrazole derivatives | |
GB201219289D0 (en) | Pyrazole derivatives | |
GB201218245D0 (en) | Pyrazole derivatives | |
SG10201706707VA (en) | Inhibitory oligonucleotide and use thereof | |
GB201209458D0 (en) | Novel compounds and their use as kinase inhibitors |